These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32965599)

  • 1. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.
    Mousa RF; Al-Hakeim HK; Alhaideri A; Maes M
    Metab Brain Dis; 2021 Jan; 36(1):169-183. PubMed ID: 32965599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.
    Almulla AF; Al-Rawi KF; Maes M; Al-Hakeim HK
    J Affect Disord; 2021 May; 287():316-326. PubMed ID: 33812245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways.
    Almulla AF; Al-Hakeim HK; Abed MS; Carvalho AF; Maes M
    Schizophr Res; 2020 Aug; 222():342-353. PubMed ID: 32467068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy.
    Al-Hakeim HK; Mousa RF; Al-Dujaili AH; Maes M
    Metab Brain Dis; 2021 Jun; 36(5):939-955. PubMed ID: 33580860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments.
    Al-Dujaili AH; Mousa RF; Al-Hakeim HK; Maes M
    Schizophr Bull; 2021 Mar; 47(2):530-541. PubMed ID: 32971537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity.
    Maes M; Almulla AF; Zhou B; Algon AAA; Sodsai P
    Sci Rep; 2024 Mar; 14(1):7344. PubMed ID: 38538641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6.
    Moustafa SR; Al-Rawi KF; Stoyanov D; Al-Dujaili AH; Supasitthumrong T; Al-Hakeim HK; Maes M
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32858974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
    Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum agrin and talin are increased in major depression while agrin and creatine phosphokinase are associated with chronic fatigue and fibromyalgia symptoms in depression.
    Al-Hakeim HK; Al-Issa AAR; Maes M
    Metab Brain Dis; 2020 Jan; 35(1):225-235. PubMed ID: 31734845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments.
    Almulla AF; Moustafa SR; Al-Dujaili AH; Al-Hakeim HK; Maes M
    Braz J Psychiatry; 2021; 43(2):131-137. PubMed ID: 32556004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease.
    Asad HN; Al-Hakeim HK; Moustafa SR; Maes M
    CNS Neurol Disord Drug Targets; 2023; 22(2):191-206. PubMed ID: 35366785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study.
    Al-Hakeim HK; Almulla AF; Maes M
    Neurotox Res; 2020 Mar; 37(3):753-771. PubMed ID: 31916129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
    Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
    Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia.
    Al-Hakeim HK; Almulla AF; Al-Dujaili AH; Maes M
    Curr Top Med Chem; 2020; 20(9):747-758. PubMed ID: 31994463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
    Maes M
    Neuro Endocrinol Lett; 2015; 36(4):320-9. PubMed ID: 26454487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach.
    Al-Jassas HK; Al-Hakeim HK; Maes M
    J Affect Disord; 2022 Jan; 297():233-245. PubMed ID: 34699853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.